A Phase 3, Open-Label, Multicenter Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease (CAD)
Sponsor: |
GE Healthcare |
Enrolling: |
Male and Female Patients |
Clinic Visits: |
2 |
IRB Number: |
AAAR8795 |
U.S. Govt. ID: |
NCT03354273 |
Contact: |
Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu |
Phase 3 open-label, multicenter Study of Flurpiridaz Injection for PET Imaging for assessment of Myocardial perfusion in patients referred for Invasive Coronary Angiography because of suspected Coronary Artery Disease
This study is closed
Investigator
Andrew Einstein, MD
Are you at least 18 years old? |
Yes |
No |